Go Pro
→ Your book attached (From Profits Run) (Ad)tc pixel Free QNCX Stock Alerts

Quince Therapeutics (QNCX) Earnings Date, Estimates & Call Transcripts

Quince Therapeutics logo
$23.39 +0.36 (+1.56%)
Closing price 07/31/2026 04:00 PM Eastern
Extended Trading
$23.30 -0.09 (-0.38%)
As of 07/31/2026 07:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Quince Therapeutics Earnings Summary

Quince Therapeutics announced Q1 2026 earnings on May 11, 2026, reporting an EPS of -$0.59, which topped the consensus estimate of -$26.00 by $25.41. With a trailing EPS of -$212.40, Quince Therapeutics' earnings are expected to decrease next year, from ($2.72) to ($5.35) per share.

Upcoming Q2
Earnings Date
Aug. 11Before Market OpensEstimated
Consensus EPS
(May. 11)
-$26.00
Actual EPS
(May. 11)
-$0.59 Beat By $25.41

Q1 2026 Earnings Resources

QNCX Upcoming Earnings

Quince Therapeutics' Q2 2026 earnings is estimated for Tuesday, August 11, 2026, based on past reporting schedules, with a conference call scheduled on Wednesday, August 12, 2026 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.

Powered by Quartr
Get Quince Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Quince Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

QNCX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Quince Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate
($2.72) EPS
Next Year EPS Consensus Estimate
($5.35) EPS

Quince Therapeutics Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
8/11/2026
(Estimated)		--------
5/11/2026Q1 2026-$26.00-$0.59+$25.41$57.60--
11/12/2025Q3 2025-$40.00-$50.00 -$10.00-$0.25--
8/11/2025Q2 2025-$56.00-$68.00 -$12.00-$0.34--
5/13/2025Q1 2025-$48.00-$68.00 -$20.00-$0.34--
3/24/2025Q4 2024-$38.00-$56.00 -$18.00-$0.28-$0.17M
8/13/2024Q2 2024--$36.00-$0.28--

Data powered by Fiscal.ai.

Quince Therapeutics Earnings - Frequently Asked Questions

Quince Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, August 11th, 2026 based off last year's report dates. Learn more on QNCX's earnings history.

In the previous quarter, Quince Therapeutics (NASDAQ:QNCX) reported ($0.59) earnings per share (EPS) to beat the analysts' consensus estimate of ($26.00) by $25.41. Learn more on analysts' earnings estimate vs. QNCX's actual earnings.

Quince Therapeutics (NASDAQ:QNCX) has a recorded net income of -$83.98 million. QNCX has generated -$212.40 earnings per share over the last four quarters.

Quince Therapeutics' earnings are expected to decrease from ($2.72) per share to ($5.35) per share in the next year.

Related Companies
Earnings Tools

This page (NASDAQ:QNCX) was last updated on 8/1/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
BofA: Digital Dollar Coming 2025-2030
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
Trump's gold order: the announcement they won't put on the front page
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel